SABCS 2022 Stromal Tumor-Infiltrating Lymphocytes Identify Early-Stage TNBC Patients With Favorable Outcomes at 10-Year Follow-Up in the Absence of Systemic Therapy: A Pooled Analysis of 1835 Patients

75 views
December 14, 2022
Comments 0
Login to view comments. Click here to Login